Image

I-ASV in Cardiac Surgery

Recruiting
18 - 120 years of age
Both
Phase N/A

Powered by AI

Overview

'POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients II (POSITiVE II) is an investigator-initiated, international, multicenter, parallel, randomized clinical trial in patients after cardiac surgery.

Description

To compare INTELLiVENT-ASV with conventional ventilation with respect to (i.) quality of ventilation; and (ii.) ICU nursing staff workload in an international cohort of participants receiving postoperative ventilation after cardiac surgery. This study will also determine the effects of INTELLiVENT-ASV on clinical outcomes, including (iii.) duration of postoperative ventilation and (iv.) length of stay in ICU.

Eligibility

Inclusion Criteria:

  • 1. aged > 18 years of age;
  • 2. scheduled for elective cardiac surgery; and
  • 3. expected to receive postoperative ventilation in the ICU for > 2 hours.

Exclusion Criteria:

  1. any emergency or semi-elective surgery (precluding informed written consent);
  2. any surgery other than CABG, valve replacement or repair, or a combination (i.e., patients planned for surgery for congenital heart disease, or scheduled for heart transplantation are excluded);
  3. enrolled in another interventional trail;
  4. no written informed consent obtained;
  5. history of recent pneumectomy or lobectomy;
  6. history of COPD with oxygen at home;
  7. body mass index > 35;
  8. preoperative forced expiratory volume in the first second (FeV1)/forced vital capacity (VC) < 50% (if available);
  9. preoperative arterial oxygen partial pressure (PaO2) < 60 mm Hg (at room air);
  10. preoperative arterial carbon dioxide partial pressure (PaCO2) > 50 mm Hg;
  11. preoperative left ventricular ejection fraction < 30% (if available);
  12. preoperative systolic pulmonary artery pressure > 60 mm Hg (if available);
  13. preoperative left ventricular mechanical support, e.g., Impella®; or
  14. preoperative use of veno-venous or veno-arterial extracorporeal support

    At the end of surgery, patients are additionally excluded if a patient:

  15. cannot be weaned from the extracorporeal support; or
  16. unexpectedly needs implementation of an assist device

Study details

Ventilator Lung

NCT06178510

Medical University of Vienna

11 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.